DGX, LH And ISRG, Pushing Health Services Industry Downward

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 76 points (0.5%) at 15,300 as of Tuesday, July 9, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 2,101 issues advancing vs. 849 declining with 106 unchanged.

The Health Services industry currently sits down 0.5% versus the S&P 500, which is up 1.2%. A company within the industry that fell today was Abbott Laboratories ( ABT), up 0.9%. A company within the industry that increased today was Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.3%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Quest Diagnostics ( DGX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Quest Diagnostics is down $3.18 (-5.2%) to $58.06 on heavy volume. Thus far, 2.7 million shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $56.81-$59.39 after having opened the day at $56.98 as compared to the previous trading day's close of $61.24.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. Quest Diagnostics has a market cap of $9.6 billion and is part of the health care sector. Shares are up 5.1% year to date as of the close of trading on Monday. Currently there is 1 analyst that rates Quest Diagnostics a buy, 2 analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Quest Diagnostics Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Laboratory Corporation of America Holdings ( LH) is down $4.30 (-4.3%) to $95.85 on heavy volume. Thus far, 1.0 million shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 807,500 shares. The stock has ranged in price between $95.63-$98.19 after having opened the day at $97.92 as compared to the previous trading day's close of $100.15.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $9.3 billion and is part of the health care sector. Shares are up 15.6% year to date as of the close of trading on Monday. Currently there is 1 analyst that rates Laboratory Corporation of America Holdings a buy, 2 analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Laboratory Corporation of America Holdings Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Intuitive Surgical ( ISRG) is down $89.43 (-17.9%) to $410.65 on heavy volume. Thus far, 3.7 million shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 330,500 shares. The stock has ranged in price between $409.71-$429.88 after having opened the day at $428.00 as compared to the previous trading day's close of $500.08.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $20.2 billion and is part of the health care sector. Shares are up 2.8% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Intuitive Surgical a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

'When I Think of October, I Think of Black Monday' -- Market Recon

'When I Think of October, I Think of Black Monday' -- Market Recon

Cramer: These Sectors Look Bullish (Part III)

Cramer: These Sectors Look Bullish (Part III)

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

Stanley Black & Decker, Quest Diagnostics and 2 More Could Rocket Higher This Spring -- Here's Why

Stanley Black & Decker, Quest Diagnostics and 2 More Could Rocket Higher This Spring -- Here's Why